GATA3 promotes ferroptosis resistance by repressing integrin β1 signaling

Area of Science:

• Cell Biology
• Cancer Research
• Molecular Mechanisms

Background:

• Ferroptosis is a regulated cell death pathway with implications for cancer therapy.
• Breast tumors exhibit cellular heterogeneity, with varying sensitivities to ferroptosis.
• Understanding resistance mechanisms is crucial for developing effective cancer treatments.

Purpose of the Study:

• To investigate the mechanisms underlying ferroptosis resistance in heterogeneous breast tumors.
• To identify specific cell populations and molecular factors contributing to ferroptosis resistance.
• To elucidate the signaling pathways involved in ferroptosis sensitivity and resistance.

Main Methods:

• Single-cell RNA-sequencing to analyze cell population differences.
• Bioinformatic analysis to identify key regulatory factors.
• Experimental validation of gene function and signaling pathways.

Main Results:

• Luminal breast cancer cells are more resistant to ferroptosis than other cell types.
• The transcription factor GATA3 promotes ferroptosis resistance in luminal cells by repressing integrin β1 expression.
• Integrin β1 signaling, via a FAK/ROCK pathway, is essential for ferroptosis sensitivity in basal cells by maintaining ACSL4 expression.

Conclusions:

• GATA3-mediated repression of integrin β1 signaling is a key mechanism of ferroptosis resistance in luminal breast cancer.
• Integrin β1 signaling is necessary for ferroptosis sensitivity in basal breast cancer cells.
• These findings offer insights into the diverse mechanisms of ferroptosis regulation within breast tumors.